CHANGMAO BIO (00954.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Aug18

CHANGMAO BIO released FY2025 Q1 earnings on August 18 (BJT), actual revenue HKD 145.8 M, actual EPS HKD -0.026

15:00

CHANGMAO BIO released FY2025 Semi-Annual earnings on August 18 After-Market (BJT), actual revenue HKD 294.81 M, actual EPS HKD -0.0527

11:00

CHANGMAO BIO released FY2025 Q2 earnings on August 18 After-Market (BJT), actual revenue HKD 149.01 M, actual EPS HKD -0.0266

11:00

Aug10

CHANGMAO BIO to Release FY2025 Semi-Annual Earnings on August 18, 2025 (BJT)

00:15

Jun30

Changmao Dalian Signs Sale and Leaseback Contract

13:17

Mar28

CHANGMAO BIO released FY2024 Q3 earnings on March 28 (BJT), actual revenue 150.19 M HKD, actual EPS -0.0517 HKD

15:00

Schedules & Filings

Schedules

Filings

Aug18

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 149.01 M, Net Income -14.11 M, EPS -0.0266

Mar28

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 144.15 M, Net Income -26.31 M, EPS -0.0496

Aug16

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 168.59 M, Net Income -10.09 M, EPS -0.019

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More